RAB18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.505200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.512200E-01
Normal-vs-Stage2
6.044200E-01
Normal-vs-Stage3
2.431400E-01
Normal-vs-Stage4
7.498600E-01
Stage1-vs-Stage2
5.258200E-01
Stage1-vs-Stage3
2.116400E-01
Stage1-vs-Stage4
6.470000E-01
Stage2-vs-Stage3
3.521200E-01
Stage2-vs-Stage4
2.531400E-01
Stage3-vs-Stage4
2.053000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.130400E-01
Normal-vs-AfricanAmerican
7.792800E-01
Normal-vs-Asian
5.616200E-01
Caucasian-vs-AfricanAmerican
2.427400E-01
Caucasian-vs-Asian
7.772400E-01
AfricanAmerican-vs-Asian
2.820000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.013200E-01
Normal-vs-Female
7.333600E-01
Male-vs-Female
4.519000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.468600E-01
Normal-vs-Age(41-60Yrs)
8.581000E-01
Normal-vs-Age(61-80Yrs)
4.603800E-01
Normal-vs-Age(81-100Yrs)
2.135600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.776000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.775600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.093400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.581390E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.604100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.091800E-01
Normal-vs-Daily Drinker
3.247000E-01
Normal-vs-Weekly Drinker
6.065600E-01
Normal-vs-Occasional Drinker
9.543400E-01
Normal-vs-Social Drinker
7.632200E-01
Non Drinker-vs-Daily Drinker
7.237600E-01
Non Drinker-vs-Weekly Drinker
6.377200E-01
Non Drinker-vs-Occasional Drinker
1.522180E-01
Non Drinker-vs-Social Drinker
6.404400E-01
Daily Drinker-vs-Weekly Drinker
4.631400E-01
Daily Drinker-vs-Occasional Drinker
1.034200E-01
Daily Drinker-vs-Social Drinker
4.627600E-01
Weekly Drinker-vs-Occasional Drinker
4.465400E-01
Weekly Drinker-vs-Social Drinker
9.144400E-01
Occasional Drinker-vs-Social Drinker
6.009800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.216410E-01
Normal-vs-Grade 2
1.649600E-02
Normal-vs-Grade 3
7.694300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.048800E-01
Grade 1-vs-Grade 3
9.750000E-01
Grade 1-vs-Grade 4
1.216410E-01
Grade 2-vs-Grade 3
4.359400E-01
Grade 2-vs-Grade 4
1.649600E-02
Grade 3-vs-Grade 4
7.694300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.732600E-01
Normal-vs-NonDiabetic
5.679400E-01
Diabetic-vs-NonDiabetic
5.521600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.113600E-01
Normal-vs-NoPancreatitis
6.077600E-01
Pancreatitis-vs-NoPancreatitis
2.479200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.004400E-01
Normal-vs-N1
6.247200E-01
N0-vs-N1
7.709800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.977400E-01
Normal-vs-TP53-NonMutant
6.927200E-01
TP53-Mutant-vs-TP53-NonMutant
8.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
